Position in DGX
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$648,142
+$48,641 QoQ
Shares Held
3,058
-0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#581
of 1,090 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DGX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Ballentine Partners, LLC holds $12,975,489 across 11 Diagnostics & Research names. DGX ranks #6 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
7,469 | $3,744,655 | |
| 2 | DHR |
Danaher Corp /De/
|
14,159 | $2,697,004 | |
| 3 | ILMN |
Illumina, Inc.
|
12,679 | $2,229,347 | |
| 4 | WAT |
Waters Corp /De/
|
2,310 | $866,340 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
1,362 | $717,010 | |
| 6 | DGX |
Quest Diagnostics Inc
This page
|
3,058 | $648,142 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
495 | $632,365 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
2,177 | $420,639 |
All Filings in DGX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $648,142 | 3,058 | Shares | Other | 2026-07-17 | |
| 2026-03-31 | $599,501 | 3,059 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $662,710 | 3,819 | Shares | Other | 2026-02-03 | |
| 2025-09-30 | $745,166 | 3,910 | Shares | Other | 2025-11-03 | |
| 2025-06-30 | $688,341 | 3,832 | Shares | Other | 2025-07-15 | |
| 2025-03-31 | $622,825 | 3,681 | Shares | Other | 2025-05-01 | |
| 2024-12-31 | $204,264 | 1,354 | Shares | Other | 2025-01-16 | |
| No filing history on record for this holder in this stock. | ||||||